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Abstract
Eosin B (EoB) and eosin Y (EoY), two xanthene dye derivatives with photosensitizing ability were prepared in high purity through
an improved synthetic route. The dyes were grafted to a 6-monoamino-β-cyclodextrin scaffold under mild reaction conditions
through a stable amide linkage using the coupling agent 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride. The
molecular conjugates, well soluble in aqueous medium, were extensively characterized by 1D and 2D NMR spectroscopy and mass
spectrometry. Preliminary spectroscopic investigations showed that the β-cyclodextrin–EoY conjugate retains both the fluores-
cence properties and the capability to photogenerate singlet oxygen of the unbound chromophore. In contrast, the corresponding
β-cyclodextrin–EoB conjugate did not show either relevant emission or photosensitizing activity probably due to aggregation in
aqueous medium, which precludes any response to light excitation.
Introduction
Cyclodextrins (CDs) are cyclic oligosaccharides able to form
host–guest inclusion complexes with drugs and this property
can be utilized to protect the guest molecules from oxidation
and degradation, to enhance their solubility and bioavailability,
or to use the CD host as a drug carrier [1]. The potential appli-
cation of these macrocyclic sugars in such pharmaceutical
formulations required the understanding of the mechanism of
their action and their fate inside living cells. The fluorescent
labeling of CDs enables their tracking and visualization in bio-
logical media and provides useful information about their cell-
membrane-penetration ability [2,3]. Besides, fluorophore-
appended CDs have been extensively studied and successfully
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utilized in photodynamic therapy (PDT). This minimally inva-
sive therapeutic approach has proven to be very well-suited for
cancer and bacterial diseases treatment. The PDT is based on
the combination of three main components: visible light, a
photosensitizer (PS) and molecular oxygen [4,5]. After being
excited with visible light, the PS – while reverting to the ground
state – transfers the energy of its lowest excited triplet state to
nearby molecular oxygen. This leads to an in situ generation of
singlet oxygen (1O2), which is the main responsible species for
cytotoxic reactions in cells [6]. Singlet oxygen offers important
advantages over conventional drugs as it: i) potentially attacks
biological substrates of different nature (i.e., lipids, proteins,
and DNA), ii) does not suffer from multidrug resistance (MDR)
problems, and iii) due to its short half-life (<0.1 ms) and lack of
charge, it diffuses in the cellular environment over short dis-
tances (few tens of nm) resulting in negligible systemic side
effects.
For PDT applications CDs have been conjugated with porphy-
rin [7] and protoporphyrin (5-aminolevulinic acid) [8] in order
to enhance the membrane penetration of the PS (or its prodrug),
to increase the aqueous solubility and to prevent the undesired
aggregation of the PS inside the cell. Another advantage offered
by the covalently connected CD–PS systems is the encapsula-
tion of hydrophobic photoactivatable drug molecules in the CD
cavity, enabling thereby the application of these systems in
combined phototherapies. This approach has recently led to
self-assembled systems based on a porphyrin–β-CD conjugate
and a tailored nitric oxide photoreleaser forming a strong inclu-
sion complex with the β-CD cavity [9]. This supramolecular
nanoassembly simultaneously releases cytotoxic 1O2 and nitric
oxide under illumination with visible light, resulting in ampli-
fied cancer-cell mortality [9]. By attaching porphyrin to γ-CD
and dimeric β-CD, which are both able to form inclusion com-
plexes with cytotoxic drug molecules such as doxorubicin and
paclitaxel, nanocarriers with multimodal therapeutic effects
(PDT and chemotherapy) have been developed by Král et al.
[10,11]. The results achieved by these groups clearly demon-
strated the numerous advantages of the PS–CD coupling. How-
ever, despite the number of porphyrinoid PSs conjugated with
CDs [12-20], literature on xanthene-type PSs in conjugation
with CDs is very scarce. The reasons behind this fact are most
probably the difficulties in selective CD functionalization and
limitations in xanthene-dye modification.
Xanthene dyes can be introduced into the CD scaffold most
easily through an ester linkage between the available hydroxy
groups of the CD and the carboxylic acid group of the dye [21].
These conjugates, however, cannot be used in biomedical appli-
cations because of the lability of the ester bond towards enzy-
matic degradation. Any cleavage of the conjugate would result
in an increased free dye concentration in the studied medium
and consequently it would lead to false positive results in
microscopic studies or in undesired aggregation of the free PS.
To circumvent this drawback and to ensure the stability of the
dye-appended CD derivatives, different strategies using thio-
ureido [3] or amide [22] connections have been developed.
Fenyvesi and Jicsinszky applied thioureido chemistry to attach
fluoresceinyl isothiocyanate to randomly methylated
6-monoamino-β-CD as a possible sensor for soluble contami-
nants in groundwater [23]. In the conjugate obtained, the
stability of the formed thioureido moiety also made possible its
biological application and since the introduction of this strategy
a wide variety of xanthene-dye-appended CDs have been de-
veloped [24,25] using the same methodology. However, the
major drawbacks of this approach is the extremely high price of
the isothiocyanate pre-modified xanthene starting materials and
the harsh reaction conditions (pyridine as a solvent, reflux, ad-
ditional base) necessary for the successful coupling. These
factors called for an easy-to-perform and widely applicable ap-
proach towards xanthene-dye-modified CDs. This was achieved
with the aid of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-
morpholinium chloride (DMTMMCl), a coupling reagent
frequently used in peptide synthesis. Malanga et al. recently re-
ported on the preparation of xanthene-dye-appended CDs with
the most commonly used fluorescent probes rhodamine and
fluorescein (Flu, 1). The conjugation of the 6-monoamino-β-CD
scaffold was achieved through amide-bond formation between
the amino-CD and the carboxylic group of the xanthene dyes
[26]. This strategy does not require the laborious isothiocyanate
functionalization and it can be applied to all xanthene dyes
having a carboxylic function. Encouraged by these results we
decided to use this method for the coupling with xanthene dyes
which upon light irradiation are able to generate cytotoxic 1O2.
The coupled products would thus represent a new family of
photosensitizers, the eosin-CDs (Eo–CDs). Although the photo-
bactericidal activity of Eo dyes is well known from the litera-
ture [27,28], to the best of our knowledge Eo–CD conjugates
have not been prepared up to date.
Results and Discussion
Synthesis of eosin Y (EoY, 2) and eosin B
(EoB, 4)
The purity of the commercially available dyes eosin Y and
eosin B, purchased from different providers (two different
sources for each dye were tested) was not suitable for the prepa-
ration of the β-CD conjugates. The 1H NMR spectra and TLC
analysis of the commercially available dyes are provided in
Supporting Information File 1, Figures S1 and S2, Figures S8
and S9 and Figures S41 and S42, respectively. Therefore, both
dyes were freshly synthesized starting from fluorescein (Flu, 1).
Although the described synthetic procedures for the preparation
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Figure 1: Reaction scheme for the synthesis of eosin Y (2) and eosin B (4).
of eosin dyes commonly use Br2, herein the less hazardous
N-bromosuccinimide (NBS) was used as the source of bromine.
Thus, eosin Y (2) was prepared in a single step from 1 in
ethanol in the presence of NBS (Figure 1). The detailed descrip-
tion of the syntheses is reported in Supporting Information
File 1.
The synthesis of EoB (4) was performed in two steps: first,
dibromofluorescein (3) was synthesized through partial bromi-
nation of 1 with NBS in acetic acid (Figure 1). However, under
the selected reaction conditions, a three-component mixture of
mono-, di- and tribromofluorescein was obtained and the isola-
tion of the targeted dibrominated product 3 from this crude was
extremely laborious and low yielding. On the other hand, when
using NBS in a slight excess (2.5-fold molar excess with respect
to 1) only a two-component mixture of di- and tribromofluores-
cein was formed. The isolation of 3 from this crude was easily
achieved through direct-phase silica gel column chromatogra-
phy with isocratic chloroform/methanol elution. Herewith the
overbrominated byproduct was permanently immobilized on the
silica gel column and only the targeted dibromofluorescein (3)
was eluted. The structure of compound 3 was elucidated with
the aid of 1D and 2D NMR experiments (Supporting Informa-
tion File 1, Figures S10–S14). In the following step, dibromi-
nated fluorescein 3 was nitrated using standard nitration condi-
tions to obtain the desired dye eosin B (4) (Figure 1). The NMR
spectra showing the structure elucidation of the free dyes
eosin Y (2) and eosin B (4) are shown in Supporting Informa-
tion File 1, Figures S3–S7 and Figures S15–S19, respectively.
Synthesis of eosin Y–β-CD and eosin B–β-
CD conjugates
The condensation reaction between 6-monoamino-β-CD and the
synthesized dyes 2 and 4 is shown in Figure 2.
The reaction is promoted by the coupling agent DMTMMCl
that enables an effective conjugation in water under mild reac-
tion conditions (room temperature). Since a successful conden-
sation requires the amino function to be in the free base form,
an additional base N-methylmorpholine (NMM) was added. All
reactants are well soluble in water resulting in a homogenous
reaction mixture and in both cases the coupling proceeded at
room temperature within 3 h for eosin Y (2) and 12 h in case of
eosin B (4). TLC analysis of the crude reaction mixture gave the
first unambiguous evidence for the successful conjugate forma-
tion as the formed products have an Rf value distinct from those
of the other starting materials. Additionally the products show
intensive absorbance after excitation at 254 nm and 366 nm and
they are carbonizable. Thus the products exhibit the expected
characteristics of a fluorescent CD conjugate (Figure 3). Work-
up of the reactions included the concentration of the reaction
mixtures and selective precipitation of the CD-related com-
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Figure 2: Reaction scheme for the synthesis of eosin-appended β-CDs, 2–β-CD and 4–β-CD (NMM: N-methylmorpholine).
Figure 3: TLC analysis of the composition of the crude coupling reaction mixtures.
pounds (conjugate and unreacted starting material) with ace-
tone. As the free dyes, NMM, DMTMM-related products and
other reaction impurities are all well soluble in a water/acetone
mixture, they can easily be removed by washing the precipi-
tates with sufficient amounts of these solvents. In order to sepa-
rate the target conjugates from unreacted 6-monoamino-β-CD
(5–10% based on TLC evaluation, see Figure 3), the precipitate
was subjected to direct-phase column chromatography using an
acetonitrile (ACN)/H2O/NH3 elution mixture, in which the
faster eluting component is the conjugate and the slower is the
unreacted aminocyclodextrin which can be eventually recov-
ered.
NMR characterization of eosin-appended
β-CDs, 2–β-CD and 4–β-CD
Solutions in deuterated DMSO (DMSO-d6) were used for NMR
measurements, in order to preserve a molecularly dispersed
form of the CD derivatives during characterization. The
1H NMR spectra of both conjugates have the typical fingerprint
signals for the asymmetric, 6-monosubstituted β-cyclodextrins.
Generally two sets of signals can be identified (Figure 4 and
Figure S20 in Supporting Information File 1): the first set
comprises the aromatic protons of the eosin dyes that are ob-
served between 6.35–7.75 ppm, while the second one is formed
by the CD resonances in the range of 3.0–5.9 ppm. The CD
region also includes the proton resonances from the primary OH
groups (4.34–4.49 ppm) and the resonances of the protons from
the secondary OH groups (5.53–5.93 ppm) of the CD. DEPT-
edited HSQC spectra for both products confirm the character-
istic signal pattern of a 6-substituted β-CD, having the C6 car-
bon atom of the substituted glucose unit shifted towards lower
fields (42.27 ppm) (Figure S24 and Figure S32 in Supporting
Information File 1). This chemical shift of the C6 carbon atom
of the substituted glucose unit is also a good indicator for the
Beilstein J. Org. Chem. 2017, 13, 543–551.
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Figure 4: 1H NMR spectrum of 2–β-CD with partial assignment (DMSO-d6, 600 MHz, 298 K).
successful amide-bond formation, as this signal in the starting
material, 6-monoamino-β-CD, is found at slightly higher fields
– around 40 ppm. The coupling effectivity is further confirmed
by the presence of a single signal at around 168 ppm in the
13C NMR spectra which is assigned to the carbon atom of the
amide group of the conjugates (see Figures S21 and S29 in Sup-
porting Information File 1).
In the 1H NMR spectra of both conjugates, the signals of the
anomeric protons are well separated from the aromatic protons
and from other CD-related resonances (Figure 4 and for the
spectrum of conjugate 4–β-CD, see Figure S20 in Supporting
Information File 1). Therefore these protons provide a good
reference for the determination of the degree of substitution
(DS) of the molecules. The comparison of the intensities of the
anomeric protons with those of the aromatic protons unambigu-
ously confirms the monosubstitution pattern (DS = 1) in both
cases and was further proven by electrospray ionization mass
spectrometry (ESIMS) analysis of the compounds (see Support-
ing Information File 1). The signals in the aromatic region are
well resolved (see Figures S25 and S33, Supporting Informa-
tion File 1) and the in-depth analysis of the DEPT-edited HSQC
spectra supported by COSY data (Figures S23 and S31, Sup-
porting Information File 1), allowed the complete assignment of
the aromatic resonances. Additional 2D NMR spectra (HMBC
and ROESY) for the eosin–β-CD conjugates are also included
in Supporting Information File 1, Figures S26 and S27 and
Figures S34–S36).
To summarize, the compounds were prepared in good purity
and a thorough investigation by NMR spectroscopy revealed
that the compounds are monosubstituted on the primary side.
Aggregation properties of eosin–β-CD conju-
gates by dynamic light scattering
For the investigation of the aggregation properties, solutions of
the eosin–β-CD conjugates in water were used. A concentration
of 1 mM of the conjugates Eo-β-CDs was applied to obtain reli-
ably high scattered intensities for the characterization. Figure 5
shows that the aggregation behavior of eosin B (4)– and
eosin Y (2)–β-CD conjugates significantly differ from each
other. The size distribution of 2–β-CD shows that the sample is
essentially monodisperse with a peak at around 5 nm and this
behavior is also observed by transforming the results into
volume-related data (see Figure S39 in Supporting Information
File 1). On the other hand, the conjugate 4–β-CD is more likely
to form large aggregates. Aggregate populations with sizes of
approximately 100–300 nm as well as 5000–6000 nm were
Beilstein J. Org. Chem. 2017, 13, 543–551.
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Figure 5: Size distributions of 1 mM aqueous solutions of conjugates 4–β-CD (a) and 2–β-CD (b) at 25.0 °C (pH 7) by intensity (three parallel mea-
surements: blue, green and red lines).
found for cyclodextrin conjugate with dye 4 both in the intensi-
ty vs size-distribution plot as well as in the volume plot (see
Figure S39 in Supporting Information File 1).
The aggregation properties of 4–β-CD were further confirmed
by the results obtained by nanoparticles tracking analysis
(Figure S40, Supporting Information File 1). The sample, under
the selected experimental conditions, is rather polydisperse and
differently sized populations can be detected. The strong aggre-
gation character of 4–β-CD can remarkably influence the spec-
troscopic and photophysical properties of the conjugate.
UV–vis spectroscopic and photophysical
properties of eosin–β-CD conjugates
Preliminary spectroscopic investigations on the conjugates were
carried out in aqueous solutions. Figure 6 shows the absorption
and fluorescence emission spectra of eosin Y conjugate 2–β-CD
and, for comparison, of the free dye 2. Apart from a slight red
shift of the absorption maximum, the absorption spectral profile
in the visible region of the conjugate is similar to that of the free
dye, ruling out any relevant aggregation phenomena. This
hypothesis was well confirmed by the fluorescence emission
spectrum, which exhibits an intense band maximum at 550 nm.
The fluorescence quantum yield was Φf = 0.20, which is very
close to the value reported for free eosin Y (2) [29].
On the other hand, the fluorescence decay of the conjugate was
different from that of the isolated dye 2. Figure 7 illustrates the
fluorescence decay traces observed in both cases. The analysis
of the fluorescence decay in case of 2 was fitted by a biexpo-
nential kinetic with a longer, dominant lifetime (τ) of 1.44 ns
(83%) and a minor shorter component of 0.48 ns (17%). The
decay of the 2–β-CD conjugate was more complex and was
fitted by a triexponential fit with lifetimes of 4.26 ns (3%), 1.77
ns (45%) and below 0.2 ns (52%). This behavior may tenta-
tively be attributed to populations of fluorophores probably
interacting in a different way with the CD cavity.
As outlined in the introduction, singlet oxygen, 1O2, is the key
species involved in PDT and it is generated by energy transfer
Beilstein J. Org. Chem. 2017, 13, 543–551.
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Figure 6: Normalized absorption spectra of aqueous solutions of
(a) eosin Y (2) and (b) conjugate 2–β-CD and fluorescence emission
spectra of aqueous solutions of (c) 2 and (d) 2–β-CD. λexc = 490 nm.
The fluorescence spectra were recorded with the two samples having
the same absorbance at the excitation wavelength.
from the excited triplet state of a PS and the nearby molecular
oxygen. Although several indirect methodologies based on suit-
able chemical traps are well known to detect 1O2 formation, the
best experimental method to prove and quantify its production
is its direct detection. It is based on the monitoring of the
typical phosphorescence of 1O2 in the near-IR spectral window
[30]. As shown in Figure 8, excitation of the conjugate 2–β-CD
with visible green light generates the characteristic lumines-
cence signals with a maximum at ca. 1270 nm analogously to
what observed for free dye 2. We obtained a 1O2 quantum yield
ΦΔ = 0.47, that is very similar to that of the free dye in the same
solvent (ΦΔ = 0.49) [31]. This result excludes any significant
intra- or interencapsulation of the excited triplet state of the dye
within the β-CD. If this was the case, the reduced quenching by
oxygen due to steric hindrance would have resulted in a much
smaller value for ΦΔ.
The corresponding 4–β-CD conjugate did not show either
detectable fluorescence emission or 1O2 photogeneration. This
is not surprising in light of the observed massive aggregation of
Figure 7: Time-resolved fluorescence observed for aqueous solutions
of (a) eosin Y (2) and (b) the 2–β-CD conjugate. λexc = 455 nm; λem =
570 nm.
Figure 8: 1O2 luminescence detected upon 528 nm light excitation of
D2O solutions of (a) eosin Y (2) and (b) 2–β-CD conjugate having the
same absorbance at the excitation wavelength.
this derivative in aqueous medium (see Figure 5). Studies cur-
rently in progress are addressed to better clarify this point and
to design strategies to circumvent this drawback and results will
be reported in the due course.
Beilstein J. Org. Chem. 2017, 13, 543–551.
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Conclusion
Two novel eosin–β-CD conjugates have been prepared through
a DMTMMCl-promoted condensation under mild reaction
conditions in water. The synthesis started from the xanthene
dyes that were prepared in high purity through an improved
synthetic route. The prepared CD conjugates have been thor-
oughly characterized by 1D and 2D NMR experiments. While
the eosin B (4)-β-CD conjugate was not light responsive, proba-
bly due to self-aggregation phenomena, the eosin Y conjugate
2–β-CD showed excellent preservation of the photophysical
properties of the dye. In fact, this molecular hybrid exhibits
satisfactory fluorescence and 1O2 photogeneration quantum
yields making it a suitable candidate for biomedical research
studies in the field of imaging and PDT applications. The possi-
bility to exploit the CD cavity as potential carrier site may also
open intriguing prospect in multimodal therapy applications.
Supporting Information
Supporting Information File 1
Syntheses, NMR spectroscopic data, ESIMS spectra, DLS
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